Lipoprotein-associated phospholipase A2: A new therapeutic target

被引：4
|
作者：
Lonn, Eva [1 ]
机构：
[1] McMaster Univ, Hamilton Hlth Sci & Populat Hlth Res Inst, Hamilton, ON, Canada
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2010年 / 26卷
关键词：
Atherosclerosis; Inflammation; Lipoprotein-associated phospholipase A(2); Plaque rupture; CORONARY-ARTERY-DISEASE; ACTIVATING-FACTOR-ACETYLHYDROLASE; C-REACTIVE PROTEIN; MIDDLE-AGED MEN; FUTURE CARDIOVASCULAR EVENTS; LOW-DENSITY-LIPOPROTEIN; HEART-DISEASE; ISCHEMIC-STROKE; RISK-FACTORS; ENDOTHELIAL DYSFUNCTION;
D O I：
10.1016/S0828-282X(10)71058-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Lipoprotein-associated phospholipase A(2) is in enzyme produced by inflammatory cells, which binds to apolipoprotein B-containing lipoproteins and degrades oxidatively modified phospholipids in low-density lipoprotein cholesterol pail-iciest leading to formation of proinflammatory and cytotoxic products. Experimental studies suggest a role for lipoprotein-associated phospholipase A(2) in the formation of advanced rupture-prone artherosclerotic lesions, and epidemiological investigations have linked it to increased cardiovascular risk. Ongoing trials are evaluating the role of novel pharmacological inhibitors of this enzyme, such its darapladib, in the management or high-risk coronary artery disease patients.
引用
收藏
页码：27A / 31A
页数：5
相关论文
共 50 条
  • [41] The Spin Stops Here: Inhibition of Lipoprotein-Associated Phospholipase A2-A Promising Target but a Negative Initial Trial?
    McConnell, Joseph P.
    Jaffe, Allan S.
    CLINICAL CHEMISTRY, 2009, 55 (01) : 21 - 23
  • [42] Lipoprotein-Associated Phospholipase A2 and Aortic Stenosis Biomarker or New Target for an Old Foe?
    Heistad, Donald
    Doshi, Hardik
    JACC-CARDIOVASCULAR IMAGING, 2015, 8 (01) : 34 - 36
  • [43] Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories
    Dhamoon, Mandip S.
    Cheung, Ying-Kuen
    Moon, Yeseon P.
    Wright, Clinton B.
    Sacco, Ralph L.
    Elkind, Mitchell S. V.
    PLOS ONE, 2019, 14 (04):
  • [44] Lipoprotein-Associated and Secretory Phospholipase A2 in Cardiovascular Disease: The Epidemiological Evidence
    Koenig, Wolfgang
    Khuseyinova, Natalie
    CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) : 85 - 92
  • [45] Lipoprotein-associated phospholipase A2 (Lp-PLA2): A novel and promising biomarker for cardiovascular risks assessment
    Cai, Anping
    Zheng, Dongdan
    Qiu, Ruofeng
    Mai, Weiyi
    Zhou, Yingling
    DISEASE MARKERS, 2013, 34 (05) : 323 - 331
  • [46] Association of lipoprotein-associated phospholipase A2 and endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA)
    Garg, Parveen K.
    McClelland, Robyn L.
    Jenny, Nancy S.
    Criqui, Michael
    Liu, Kiang
    Polak, Joseph F.
    Jorgensen, Neal W.
    Cushman, Mary
    VASCULAR MEDICINE, 2011, 16 (04) : 247 - 252
  • [47] Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors
    Acevedo, Monica
    Varleta, Paola
    Kramer, Veronica
    Quiroga, Teresa
    Prieto, Carolina
    Parada, Jacqueline
    Adasme, Marcela
    Briones, Luisa
    Navarrete, Carlos
    REVISTA MEDICA DE CHILE, 2013, 141 (11) : 1382 - 1388
  • [48] Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A2
    Nagano, Joseph M. G.
    Hsu, Ku-Lung
    Whitby, Landon R.
    Niphakis, Micah J.
    Speers, Anna E.
    Brown, Steven J.
    Spicer, Timothy
    Fernandez-Vega, Virneliz
    Ferguson, Jill
    Hodder, Peter
    Srinivasan, Prabhavathi
    Gonzalez, Tara D.
    Rosen, Hugh
    Bahnson, Brian J.
    Cravatt, Benjamin F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (03) : 839 - 843
  • [49] Lipoprotein-associated phospholipase A2 level in patients with Behcet's disease
    Orem, A.
    Yayli, S.
    Arica, D. A.
    Akcan, B.
    Yucesan, F. B.
    Bahadir, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (03) : e289 - e293
  • [50] Lipoprotein-associated phospholipase A2 activity and mass in relation to vascular disease and nonvascular mortality
    Parish, S.
    Offer, A.
    Thompson, A.
    Link, E.
    Di Angelantonio, E.
    Bowman, L.
    Armitage, J.
    Danesh, J.
    Collins, R.
    JOURNAL OF INTERNAL MEDICINE, 2010, 268 (04) : 348 - 358
12345